Sponsorships
Sage considers funding in exchange for tangible benefit(s) to organizations that are aligned to our scientific and community objectives.
Full sponsorship request details are noted below, including more information on patient advocacy and medical programs.
About Sponsorships
Types of activities may include educational events or other activities for which Sage receives a tangible benefit.
Tangible benefits may include but are not limited to:
- Advertisement in a program book
- Acknowledgement (i.e., logo)
- Product theaters
- Exhibits/booths
- Other corporate marketing opportunities
Funding Requirements
Sponsorship Requests
- Must be submitted at least 60 days in advance of when the funding decision is needed by the organization and are accepted on a rolling basis. Sage reserves the right to decline any applications not adhering to the deadline.
- Must clearly identify the tangible benefit(s) offered to Sage.
- Must include a reasonable requested amount for the activities proposed that is consistent with comparable meetings or events.
- Must include an estimate of the requesting organization's annual total expenditures.
- Will only be considered if the submission form is complete and all required documentation is included.
- All submissions must be received through the Sage Funding and Giving portal. Otherwise the request will not be considered.
Review Process & Decision
In all cases, Sage notifies applicants by email. Sage’s approval is based on several criteria including, but not limited to, our funding availability, areas of interest alignment, and the event details and agenda. All recipient organizations must abide by the terms and conditions as outlined in the Letter of Agreement (LOA), which is issued electronically to an authorized signatory of the organization once the application is approved. The organization must agree to the terms of the LOA before the start date and Sage may not receive any benefit(s) prior to LOA execution. Payment will be issued upon execution of the LOA.
Reconciliation
Within 60 days of the request end date, recipient organizations must complete a reconciliation confirming receipt of funds and attesting that Sage received the tangible benefits described in the request and LOA. An organization’s failure to appropriately submit a reconciliation by the due date may delay or prohibit future funding of applications.
Patient Advocacy Sponsorships
Sage recognizes the essential role patient advocacy groups play in making a positive, lasting impact for people with life-altering brain health disorders. We support the work of patient advocacy organizations that align with our areas of focus and strategy.
Patient advocacy areas of interest:
- Postpartum Depression
Medical Sponsorships
Sage supports healthcare professional educational opportunities and other efforts designed to address medical areas of interest related to Postpartum Depression (PPD), such as:
- Advancing integration of mental health care into OB/GYN practices. This may be through a variety of approaches designed to increase the ability of a woman's healthcare provider to (1) identify and manage patients with PPD; (2) collaborate with behavioral health practitioners, psychiatric consultants or care coordinators; and/or (3) articulate the components, principles, and impact of a perinatal collaborative care model.1,2
- Discussing ways to integrate clinical best practices into the management of patients with PPD in accordance with national organization/professional society guidance,3-7 while including explanation of the clinical rationale for consistent screening, accurate diagnosis, and expeditious care of adults with PPD.
- Facilitating open and effective dialogue between clinicians and adult patients with PPD in a manner that aligns with culturally responsive care and helps overcome stigma associated with PPD.
- Fostering innovative approaches to the detection of PPD symptoms and ways to connect women potentially experiencing PPD symptoms to care pathways and educational resources.
References
- Zimmermann M, Zahlaway J, Gaulton J, Byatt N. (2024) The Perinatal Mental Health Crisis. Psychiatric Times. 41(8):14-16.
- Taple BJ, Haldar S, Tandon SO, Reddy M, Mohr DC, Miller ES. (2022) A qualitative examination of the implementation of a perinatal collaborative care program. Primary Health Care Research & Development. 23(e51): 1-11. doi: 10.1017/ S146342362200038X
- Postpartum Depression Screening and Follow-up (PDS-E). Accessed October 22, 2024. https://www.ncqa.org/hedis/measures/postpartum-depression-screening-and-follow-up/
- Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum. Clinical Practice Guideline No. 4. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2023;141(6):1232-1261. doi: 10.1097/AOG.0000000000005200
- Treatment and Management of Mental Hea1th Conditions During Pregnancy and Postpartum. Clinical Practice Guideline No. 5 . American College of Obstetricians and Gynecologists. Obstet Gynecol. 2023;141(6):1262-1288. doi: 10.1097/AOG.0000000000005202
- Zuranolone for the Treatment of Postpartum Depression. Updated January 30, 2024. Accessed October 22, 2024. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2023/08/zuranolone-for-the-treatment-of-postpartum-depression
- Moore Simas TA, Whelan A, Byatt N. Postpartum Depression—New Screening Recommendations and Treatments. JAMA. 2023;330(23):2295-2296. doi:10.1001/jama.2023.21311
